TIDMFARN
RNS Number : 8780Z
Faron Pharmaceuticals Oy
22 May 2019
Faron Pharmaceuticals Ltd
("Faron" or the "Company")
Grant of options
TURKU - FINLAND, 22 May 2019 - Faron (LON: FARN), the clinical
stage biopharmaceutical company, announces that on 21 May 2019 the
Board of Faron confirmed the grant of a total of 460,000 D options
over ordinary shares in the Company ("Options") under the Faron
2015 Option Plan. The Options have been allocated under the Faron
2015 Option Plan and are exercisable between 8 October 2018 and 30
September 2021 at an exercise price of 109 euro cents per share.
The exercise price is calculated based on the average share price
between 1 July and 30 September 2018. The terms of the 2015 Option
Plan, are as described in the Company's Admission Document
(available on the Company's website) as amended at the Company's
2017 annual general meeting, details of which were announced on 16
May 2017.
The granted 460,000 Options entitle the option holders to
subscribe for a total of 460,000 new ordinary shares in the
Company, if exercised in full, and represent 1.2% of the
fully-diluted ordinary share capital of the Company.
Included in the number of Options granted are the following
Options which were issued to Directors and other persons
discharging managerial responsibilities ("PDMRs"):
Director Options granted
Markku Jalkanen 80,000
Frank Armstrong 40,000
Yrjö E K Wichmann 30,000
Matti Manner 20,000
Leopoldo Zambeletti 20,000
Gregory Brown 20,000
John Poulos 20,000
Total Directors 230,000
PDMRs
Matti Karvonen 30,000
Jami Mandelin 30,000
Maria Lahtinen 25,000
Juho Jalkanen 30,000
Pessi Honkasalo 20,000
Total PDMRs 135,000
For more information please contact:
Faron Pharmaceuticals Ltd
Dr Markku Jalkanen, Chief Executive Officer
investor.relations@faron.com
Consilium Strategic Communications
Mary-Jane Elliott, David Daley, Lindsey Neville
Phone: +44 (0)20 3709 5700
E-mail: faron@consilium-comms.com
Panmure Gordon (UK) Limited, Nomad and Broker
Emma Earl, Freddy Crossley (Corporate Finance)
James Stearns (Corporate Broking)
Phone: +44 207 886 2500
Westwicke Partners, IR (US)
Chris Brinzey
Phone: 01 339 970 2843
E-Mail: chris.brinzey@westwicke.com
About Faron Pharmaceuticals Ltd
Faron (AIM:FARN) is a clinical stage biopharmaceutical company
developing novel treatments for medical conditions with significant
unmet needs. The Company currently has a pipeline focusing on acute
organ traumas, vascular damage and cancer immunotherapy. The
Company's lead candidate Traumakine, to prevent vascular leakage
and organ failures, is currently the only treatment for Acute
Respiratory Distress Syndrome (ARDS) undergoing Phase III clinical
trials and in 2017 received advice from US FDA to proceed directly
to BLA submission following completion of EU and Japanese Phase III
studies. There is currently no approved pharmaceutical treatment
for ARDS. An additional European Phase II Traumakine trial is
underway for the Rupture of Abdominal Aorta Aneurysm ("RAAA").
Faron's second candidate Clevegen is a ground breaking pre-clinical
anti-Clever-1 antibody. Clevegen has the ability to switch immune
suppression to immune activation in various conditions, with
potential across oncology, infectious disease and vaccine
development. This novel macrophage-directed immuno-oncology switch
called Turn-on-your-Immunity or Turn-It may be used alone or in
combination with other immune checkpoint molecules for the
treatment of cancer patients. Faron is based in Turku, Finland.
Further information is available at www.faron.com
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- ----------------------------------------------------------------------------------------
a. Name Markku Jalkanen
-----------------------------------------------------------
2 Reason for notification
--------------------------- -----------------------------------------------------------
a. Position/Status Person discharging managerial responsibilities
--------------------------- -----------------------------------------------------------
b. Initial notification/ Initial Notification
Amendment
--------------------------- -----------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------
a. Name Faron Pharmaceuticals Oy
---------------------------
b. LEI 7437009H31TO1DC0EB42
--------------------------- -----------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- ----------------------------------------------------------------------------------------
a. Description of Options over ordinary shares
the financial
instrument, type ISIN: FI4000153309
of instrument
Identification
Code
--------------------------- -----------------------------------------------------------
b. Nature of the Grant of options made pursuant to the Faron
transaction 2015 Option Plan exercisable at 109 Euro
cents per Ordinary Share
--------------------------- -----------------------------------------------------------
c. Price(s) and volume(s) Price(s) Volume(s)
--------------------------- -------------
Nil 80,000
---------------------------------------------------- ------------
d. Aggregated information
- Aggregated Volume 80,000
- Price Nil
--------------------------- -----------------------------------------------------------
e. Date of the transaction 21 May 2019
--------------------------- -----------------------------------------------------------
f. Place of the transaction Turku
--------------------------- -----------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- ----------------------------------------------------------------------------------------
a. Name Frank Armstrong
-----------------------------------------------------------
2 Reason for notification
--------------------------- -----------------------------------------------------------
a. Position/Status Person discharging managerial responsibilities
--------------------------- -----------------------------------------------------------
b. Initial notification/ Initial Notification
Amendment
--------------------------- -----------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------
a. Name Faron Pharmaceuticals Oy
---------------------------
b. LEI 7437009H31TO1DC0EB42
--------------------------- -----------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- ----------------------------------------------------------------------------------------
a. Description of Options over ordinary shares
the financial
instrument, type ISIN: FI4000153309
of instrument
Identification
Code
--------------------------- -----------------------------------------------------------
b. Nature of the Grant of options made pursuant to the Faron
transaction 2015 Option Plan exercisable at 109 Euro
cents per Ordinary Share
--------------------------- -----------------------------------------------------------
c. Price(s) and volume(s) Price(s) Volume(s)
--------------------------- -------------
Nil 40,000
---------------------------------------------------- ------------
d. Aggregated information
- Aggregated Volume 40,000
- Price Nil
--------------------------- -----------------------------------------------------------
e. Date of the transaction 21 May 2019
--------------------------- -----------------------------------------------------------
f. Place of the transaction Turku
--------------------------- -----------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- ----------------------------------------------------------------------------------------
a. Name Yrjö E K Wichmann
-----------------------------------------------------------
2 Reason for notification
--------------------------- -----------------------------------------------------------
a. Position/Status Person discharging managerial responsibilities
--------------------------- -----------------------------------------------------------
b. Initial notification/ Initial Notification
Amendment
--------------------------- -----------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------
a. Name Faron Pharmaceuticals Oy
---------------------------
b. LEI 7437009H31TO1DC0EB42
--------------------------- -----------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- ----------------------------------------------------------------------------------------
a. Description of Options over ordinary shares
the financial
instrument, type ISIN: FI4000153309
of instrument
Identification
Code
--------------------------- -----------------------------------------------------------
b. Nature of the Grant of options made pursuant to the Faron
transaction 2015 Option Plan exercisable at 109 Euro
cents per Ordinary Share
--------------------------- -----------------------------------------------------------
c. Price(s) and volume(s) Price(s) Volume(s)
--------------------------- -------------
Nil 30,000
---------------------------------------------------- ------------
d. Aggregated information
- Aggregated Volume 30,000
- Price Nil
--------------------------- -----------------------------------------------------------
e. Date of the transaction 21 May 2019
--------------------------- -----------------------------------------------------------
f. Place of the transaction Turku
--------------------------- -----------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- ----------------------------------------------------------------------------------------
a. Name Matti Manner
-----------------------------------------------------------
2 Reason for notification
--------------------------- -----------------------------------------------------------
a. Position/Status Person discharging managerial responsibilities
--------------------------- -----------------------------------------------------------
b. Initial notification/ Initial Notification
Amendment
--------------------------- -----------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------
a. Name Faron Pharmaceuticals Oy
---------------------------
b. LEI 7437009H31TO1DC0EB42
--------------------------- -----------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- ----------------------------------------------------------------------------------------
a. Description of Options over ordinary shares
the financial
instrument, type ISIN: FI4000153309
of instrument
Identification
Code
--------------------------- -----------------------------------------------------------
b. Nature of the Grant of options made pursuant to the Faron
transaction 2015 Option Plan exercisable at 109 Euro
cents per Ordinary Share
--------------------------- -----------------------------------------------------------
c. Price(s) and volume(s) Price(s) Volume(s)
--------------------------- -------------
Nil 20,000
---------------------------------------------------- ------------
d. Aggregated information
- Aggregated Volume 20,000
- Price Nil
--------------------------- -----------------------------------------------------------
e. Date of the transaction 21 May 2019
--------------------------- -----------------------------------------------------------
f. Place of the transaction Turku
--------------------------- -----------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- ----------------------------------------------------------------------------------------
a. Name Leopoldo Zambeletti
-----------------------------------------------------------
2 Reason for notification
--------------------------- -----------------------------------------------------------
a. Position/Status Person discharging managerial responsibilities
--------------------------- -----------------------------------------------------------
b. Initial notification/ Initial Notification
Amendment
--------------------------- -----------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------
a. Name Faron Pharmaceuticals Oy
---------------------------
b. LEI 7437009H31TO1DC0EB42
--------------------------- -----------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- ----------------------------------------------------------------------------------------
a. Description of Options over ordinary shares
the financial
instrument, type ISIN: FI4000153309
of instrument
Identification
Code
--------------------------- -----------------------------------------------------------
b. Nature of the Grant of options made pursuant to the Faron
transaction 2015 Option Plan exercisable at 109 Euro
cents per Ordinary Share
--------------------------- -----------------------------------------------------------
c. Price(s) and volume(s) Price(s) Volume(s)
--------------------------- -------------
Nil 20,000
---------------------------------------------------- ------------
d. Aggregated information
- Aggregated Volume 20,000
- Price Nil
--------------------------- -----------------------------------------------------------
e. Date of the transaction 21 May 2019
--------------------------- -----------------------------------------------------------
f. Place of the transaction Turku
--------------------------- -----------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- ----------------------------------------------------------------------------------------
a. Name Gregory Brown
-----------------------------------------------------------
2 Reason for notification
--------------------------- -----------------------------------------------------------
a. Position/Status Person discharging managerial responsibilities
--------------------------- -----------------------------------------------------------
b. Initial notification/ Initial Notification
Amendment
--------------------------- -----------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------
a. Name Faron Pharmaceuticals Oy
---------------------------
b. LEI 7437009H31TO1DC0EB42
--------------------------- -----------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- ----------------------------------------------------------------------------------------
a. Description of Options over ordinary shares
the financial
instrument, type ISIN: FI4000153309
of instrument
Identification
Code
--------------------------- -----------------------------------------------------------
b. Nature of the Grant of options made pursuant to the Faron
transaction 2015 Option Plan exercisable at 109 Euro
cents per Ordinary Share
--------------------------- -----------------------------------------------------------
c. Price(s) and volume(s) Price(s) Volume(s)
--------------------------- -------------
Nil 20,000
---------------------------------------------------- ------------
d. Aggregated information
- Aggregated Volume 20,000
- Price Nil
--------------------------- -----------------------------------------------------------
e. Date of the transaction 21 May 2019
--------------------------- -----------------------------------------------------------
f. Place of the transaction Turku
--------------------------- -----------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- ----------------------------------------------------------------------------------------
a. Name John Poulos
-----------------------------------------------------------
2 Reason for notification
--------------------------- -----------------------------------------------------------
a. Position/Status Person discharging managerial responsibilities
--------------------------- -----------------------------------------------------------
b. Initial notification/ Initial Notification
Amendment
--------------------------- -----------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------
a. Name Faron Pharmaceuticals Oy
---------------------------
b. LEI 7437009H31TO1DC0EB42
--------------------------- -----------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- ----------------------------------------------------------------------------------------
a. Description of Options over ordinary shares
the financial
instrument, type ISIN: FI4000153309
of instrument
Identification
Code
--------------------------- -----------------------------------------------------------
b. Nature of the Grant of options made pursuant to the Faron
transaction 2015 Option Plan exercisable at 109 Euro
cents per Ordinary Share
--------------------------- -----------------------------------------------------------
c. Price(s) and volume(s) Price(s) Volume(s)
--------------------------- -------------
Nil 20,000
---------------------------------------------------- ------------
d. Aggregated information
- Aggregated Volume 20,000
- Price Nil
--------------------------- -----------------------------------------------------------
e. Date of the transaction 21 May 2019
--------------------------- -----------------------------------------------------------
f. Place of the transaction Turku
--------------------------- -----------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- ----------------------------------------------------------------------------------------
a. Name Matti Karvonen
-----------------------------------------------------------
2 Reason for notification
--------------------------- -----------------------------------------------------------
a. Position/Status Person discharging managerial responsibilities
--------------------------- -----------------------------------------------------------
b. Initial notification/ Initial Notification
Amendment
--------------------------- -----------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------
a. Name Faron Pharmaceuticals Oy
---------------------------
b. LEI 7437009H31TO1DC0EB42
--------------------------- -----------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- ----------------------------------------------------------------------------------------
a. Description of Options over ordinary shares
the financial
instrument, type ISIN: FI4000153309
of instrument
Identification
Code
--------------------------- -----------------------------------------------------------
b. Nature of the Grant of options made pursuant to the Faron
transaction 2015 Option Plan exercisable at 109 Euro
cents per Ordinary Share
--------------------------- -----------------------------------------------------------
c. Price(s) and volume(s) Price(s) Volume(s)
--------------------------- -------------
Nil 30,000
---------------------------------------------------- ------------
d. Aggregated information
- Aggregated Volume 30,000
- Price Nil
--------------------------- -----------------------------------------------------------
e. Date of the transaction 21 May 2019
--------------------------- -----------------------------------------------------------
f. Place of the transaction Turku
--------------------------- -----------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- ----------------------------------------------------------------------------------------
a. Name Jami Mandelin
-----------------------------------------------------------
2 Reason for notification
--------------------------- -----------------------------------------------------------
a. Position/Status Person discharging managerial responsibilities
--------------------------- -----------------------------------------------------------
b. Initial notification/ Initial Notification
Amendment
--------------------------- -----------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------
a. Name Faron Pharmaceuticals Oy
---------------------------
b. LEI 7437009H31TO1DC0EB42
--------------------------- -----------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- ----------------------------------------------------------------------------------------
a. Description of Options over ordinary shares
the financial
instrument, type ISIN: FI4000153309
of instrument
Identification
Code
--------------------------- -----------------------------------------------------------
b. Nature of the Grant of options made pursuant to the Faron
transaction 2015 Option Plan exercisable at 109 Euro
cents per Ordinary Share
--------------------------- -----------------------------------------------------------
c. Price(s) and volume(s) Price(s) Volume(s)
--------------------------- -------------
Nil 30,000
---------------------------------------------------- ------------
d. Aggregated information
- Aggregated Volume 30,000
- Price Nil
--------------------------- -----------------------------------------------------------
e. Date of the transaction 21 May 2019
--------------------------- -----------------------------------------------------------
f. Place of the transaction Turku
--------------------------- -----------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- ----------------------------------------------------------------------------------------
a. Name Maria Lahtinen
-----------------------------------------------------------
2 Reason for notification
--------------------------- -----------------------------------------------------------
a. Position/Status Person discharging managerial responsibilities
--------------------------- -----------------------------------------------------------
b. Initial notification/ Initial Notification
Amendment
--------------------------- -----------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------
a. Name Faron Pharmaceuticals Oy
---------------------------
b. LEI 7437009H31TO1DC0EB42
--------------------------- -----------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- ----------------------------------------------------------------------------------------
a. Description of Options over ordinary shares
the financial
instrument, type ISIN: FI4000153309
of instrument
Identification
Code
--------------------------- -----------------------------------------------------------
b. Nature of the Grant of options made pursuant to the Faron
transaction 2015 Option Plan exercisable at 109 Euro
cents per Ordinary Share
--------------------------- -----------------------------------------------------------
c. Price(s) and volume(s) Price(s) Volume(s)
--------------------------- -------------
Nil 25,000
---------------------------------------------------- ------------
d. Aggregated information
- Aggregated Volume 25,000
- Price Nil
--------------------------- -----------------------------------------------------------
e. Date of the transaction 21 May 2019
--------------------------- -----------------------------------------------------------
f. Place of the transaction Turku
--------------------------- -----------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- ----------------------------------------------------------------------------------------
a. Name Juho Jalkanen
-----------------------------------------------------------
2 Reason for notification
--------------------------- -----------------------------------------------------------
a. Position/Status Person discharging managerial responsibilities
--------------------------- -----------------------------------------------------------
b. Initial notification/ Initial Notification
Amendment
--------------------------- -----------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------
a. Name Faron Pharmaceuticals Oy
---------------------------
b. LEI 7437009H31TO1DC0EB42
--------------------------- -----------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- ----------------------------------------------------------------------------------------
a. Description of Options over ordinary shares
the financial
instrument, type ISIN: FI4000153309
of instrument
Identification
Code
--------------------------- -----------------------------------------------------------
b. Nature of the Grant of options made pursuant to the Faron
transaction 2015 Option Plan exercisable at 109 Euro
cents per Ordinary Share
--------------------------- -----------------------------------------------------------
c. Price(s) and volume(s) Price(s) Volume(s)
--------------------------- -------------
Nil 30,000
---------------------------------------------------- ------------
d. Aggregated information
- Aggregated Volume 30,000
- Price Nil
--------------------------- -----------------------------------------------------------
e. Date of the transaction 21 May 2019
--------------------------- -----------------------------------------------------------
f. Place of the transaction Turku
--------------------------- -----------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- ----------------------------------------------------------------------------------------
a. Name Pessi Honkasalo
-----------------------------------------------------------
2 Reason for notification
--------------------------- -----------------------------------------------------------
a. Position/Status Person discharging managerial responsibilities
--------------------------- -----------------------------------------------------------
b. Initial notification/ Initial Notification
Amendment
--------------------------- -----------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------
a. Name Faron Pharmaceuticals Oy
---------------------------
b. LEI 7437009H31TO1DC0EB42
--------------------------- -----------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- ----------------------------------------------------------------------------------------
a. Description of Options over ordinary shares
the financial
instrument, type ISIN: FI4000153309
of instrument
Identification
Code
--------------------------- -----------------------------------------------------------
b. Nature of the Grant of options made pursuant to the Faron
transaction 2015 Option Plan exercisable at 109 Euro
cents per Ordinary Share
--------------------------- -----------------------------------------------------------
c. Price(s) and volume(s) Price(s) Volume(s)
--------------------------- -------------
Nil 25,000
---------------------------------------------------- ------------
d. Aggregated information
- Aggregated Volume 25,000
- Price Nil
--------------------------- -----------------------------------------------------------
e. Date of the transaction 21 May 2019
--------------------------- -----------------------------------------------------------
f. Place of the transaction Turku
--------------------------- -----------------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHSEAFFEFUSELI
(END) Dow Jones Newswires
May 22, 2019 07:51 ET (11:51 GMT)
Faron Pharmaceuticals Oy (LSE:FARN)
Historical Stock Chart
From Apr 2024 to May 2024
Faron Pharmaceuticals Oy (LSE:FARN)
Historical Stock Chart
From May 2023 to May 2024